BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28270206)

  • 21. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocyte Elevated Gene 1 (AEG-1) Acts as a Promoter Gene in Clear Cell Renal Cell Carcinoma Cell Growth and Metastasis.
    Yu DP; Zhou Y
    Med Sci Monit; 2018 Nov; 24():8213-8223. PubMed ID: 30431025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
    Xu J; Wang Y; Jiang J; Yin C; Shi B
    J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
    Jiang S; Liu X; Li D; Yan M; Ju C; Sun J; Jiang F
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818797587. PubMed ID: 30198403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma.
    Lu Y; Qin H; Jiang B; Lu W; Hao J; Cao W; Du L; Chen W; Zhao X; Guo H
    Cancer Lett; 2021 Dec; 522():1-13. PubMed ID: 34520818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo.
    Ji SQ; Yao L; Zhang XY; Li XS; Zhou LQ
    J Exp Clin Cancer Res; 2012 Mar; 31(1):22. PubMed ID: 22420896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
    Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
    Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W.
    Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
    Tumour Biol; 2015 Sep; 36(9):6875-82. PubMed ID: 25846734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway.
    Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X
    Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.
    Lu K; Zhao Y; Li Y; Fu Z; Chen Y; Kong Y; Li G
    J Transl Med; 2024 Jun; 22(1):533. PubMed ID: 38831470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma.
    Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H
    Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 39. PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation.
    Tao T; Yang X; Zheng J; Feng D; Qin Q; Shi X; Wang Q; Zhao C; Peng Z; Liu H; Jiang WG; He J
    Oncogene; 2017 Nov; 36(44):6119-6131. PubMed ID: 28692056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma.
    Yu C; Sun P; Zhou Y; Shen B; Zhou M; Wu L; Kong M
    Biomed Pharmacother; 2019 Oct; 118():109383. PubMed ID: 31545251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.